Clinical Trial Update: Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating whether GDC-0810 alters the exposure of pravastatin in healthy women of non-childbearing potential.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GDC-0810
• Pravastatin (pravastatin)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED